載入...
Clinical staging of NSCLC: current evidence and implications for adjuvant chemotherapy
Survival of all non-small cell lung cancer (NSCLC) patients is disappointing, with a 5-year survival of 18%. Staging NSCLC patients is crucial because it determines the choice of treatment and prognosis. Clinical staging is a complex process that comes with many challenges and with low accuracy betw...
Na minha lista:
| 發表在: | Ther Adv Med Oncol |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publications
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5564882/ https://ncbi.nlm.nih.gov/pubmed/29081843 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834017722746 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|